About this Event
- Are you a business leader of a Life Science Innovation company or investor?
- Are you interested in discussing current dealmaking and investment strategies that are working?
- Do want to learn more about other people's experiences, or share your thoughts and queries around investment & dealmaking?
- Are you looking to learn from, and meet with, your peers and experienced industry professionals and seasoned investors?
- T his #AgileLeaders Forum theme:
What are the Dealmaking & Ivestment Strategies that are working?
The life sciences and biotech sector is currently grappling with a range of investment challenges shaped by regulatory pressures, evolving market dynamics, and shifting public sentiment. As the industry strives to recover from the pandemic’s disruption, deal-making has become more cautious and complex, reflecting the demand for robust compliance and transparency.
One significant challenge is the increased regulatory scrutiny following COVID-19. Investors are now prioritizing companies with clear pathways to regulatory approval and validated clinical data. This trend influences venture capital flows, as investors seek to minimize risk by backing firms with established compliance measures. Smaller biotech companies, in particular, face hurdles in securing funding, as they often lack the resources to navigate the intricate regulatory landscape effectively. Moreover, public perception regarding drug pricing and access is steering investment decisions. Investors are more inclined to support companies that align their missions with social responsibility and ethical practices.
This societal lens encourages firms to develop narratives that emphasize not only financial viability but also positive community impact, a factor that is increasingly crucial in attracting committed investors. To address these challenges, strategic partnerships are emerging as a vital solution. Collaborations between small biotech startups and larger pharmaceutical firms can enhance credibility and access to resources, providing a safety net for navigating regulatory complexities.
Additionally, the use of non-dilutive funding—such as grants and government contracts—has gained traction, allowing companies to focus on long-term innovations without immediate financial pressures.In this evolving landscape, investment strategies that embrace transparency, collaboration, and ethical considerations will be pivotal. As the life sciences sector adapts, innovative approaches will unlock new opportunities for growth, ensuring a sustainable path forward for the future of healthcare.
Green-Shoots? We will explore what is happening in Europe and the US with experts that know the activity in the financial marketplace. We will have Bill Hicks with us from Mintz in Boston, US along with James Fry from Mills & Reeve who has his finger on the pulse regarding the UK and EU markets, along with other experts.
How you will benefit from attending Agile Leaders?
As a Business Leader, you will benefit from this "Agile" workshop by sharing common challenges and building deeper connections and trust with your peers. In turn, the aim is to build your confidence when working in areas normally outside your comfort zone, by learning and having discussions with this / your "Agile" peer network. You can speak to people in a similar position about issues you may not have the opportunity to discuss elsewhere. You can discuss your challenges with a view of learning from other people's experiences to help you find a solution or spark an idea. Why let leaders of emerging companies re-invent the wheel to be successful when we can learn from the experiences of others who have faced similar challenges before.
Chatham House Rules apply - "what goes on in the workshop, stays in the workshop - so to speak!" We are planning to write up some of the interesting features of the discussion but won't attribute anyone's comment or view so they can be identified. This is so we feel we can a free and open discussion without the worry about being quoted somewhere.
Our mission is to help you build your innovation enabled healthcare business so it is "fit for purpose," truly innovative and attractive to the global markets. Helping you build solid trustworthy networks with your peer group, and help spread your creative R&D business network nationally and internationally. Our motivation and focus is on helping you build long-term trustworthy business relationships and support you on your journey through our supportive business community.
This workshop is facilitated by Prof Tony Sedgwick, the self-professed www.ThoughtDisruptor.com. Tony has an esteemed career in life sciences in academia and in business, he is a trained pathologist. His accolades include once being the Global Head of Clinical Trials at Roche AG, and he has also been CEO of four life science companies, Chairman of over 10 Companies, and many positions within the academic community. He is also an active psychologist which is helping him develop his "Agile" community group development passion and is a Jiu-Jitsu Grand Master VI. Last year Tony published the book "The Mighty Advisor" which was a number 1 best seller in the Amazon STEM Business Management category.
We will start this Agile Leaders Forum is during "London Life Science Week" and has a 1.30 pm arrival time (with a prompt 2.00 pm start for the discussion). Our boardroom venue has kindly been provided by Mills & Reeve in their King William Street Offices, London.
Mills and Reeve have one of the largest full-service life sciences teams in the UK. Renowned lawyers with extensive expertise in the industry that will provide the solutions to enable you to seize the opportunities open to you.
For this event, we are limiting it to a maximum of 14 Life Science Leaders only. As such, we recommend you book as soon as possible to avoid disappointment.
The "Agile" workshop finishes at 17.30, at which time you will be invited to #biotechbuddies venue TBC. The evening will go on from 18.00 to 21.30 with delicious finger foods, drinks and social networking (if you would like that). Pre-Pandemic, Biotech Buddies was monthly social / business networking meet-up from all areas of the life science community. The London Biotech Buddies has regularly 60-80 life science professionals attending. Based on feedback from our community, this will be well attended by other C-level leaders, investors, experienced consultants and service providers.
Our promise to you is our Agile Leaders Forum will be like no other business workshop you have experienced. You will be walking out of the session inspired, educated and more connected.
If you are in life sciences, and at least a bit curious, then the Biotech Buddies evening networking is an occasion not to miss out on.......
In summary:
1.30-2 pm -Arrive at Mills & Reeve, 24 King William Street, London
2 pm - Agile Leaders discussion starts - Part 1
3.30-4 pm - Snacks and Refreshments
4-5.30 pm -Agile Leaders discussion - Part 2
6-9.30 pm - Biotech Buddies London - venue TBC.
FEE = £60 - ALL-INCLUSIVE - LIMITED TO 14 x C-Level Leaders of R&D Innovation companies. Of course, if you just want to come to the afternoon session only, that is fine.
Mills & Reeve is a Thought-Leadership Sponsorr of this event. They are lawyers with one of the largest full-service life sciences teams in the UK. Renowned lawyers with extensive expertise in the industry will provide the solutions to enable you to seize the opportunities open to you.
Event Venue & Nearby Stays
Mills & Reeve - Boardroom, 24 King William Street, London, United Kingdom
GBP 0.00 to GBP 60.00
